Emergent BioSolutions Inc. — Director's Dealing 2022

Feb 25, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2022-02-23

Reporting Person: Kramer Robert (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-23	Common Stock	F	1419	$42.23	Disposed	161303	Direct
2022-02-24	Common Stock	F	2034	$42.47	Disposed	159269	Direct

Footnotes

F1: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes.